Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Genetic differences affect how people respond to COVID-19.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Type I interferons play a key role in the development of various skin diseases.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Biological factors are crucial for developing new hair restoration treatments.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Inflammation damages sweat ducts, causing sweat gland injury.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Red ginseng components help prevent skin aging by reducing inflammation and improving cell function.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Dengue virus can infect human hair follicle cells and may cause hair loss.

ILC1 cells contribute to hair loss in alopecia areata.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.